Sort
39,280 grants matching “leukemia”
EASTERN COOPERATIVE ONCOLOGY GROUP
$485,561Fox Chase Cancer Center · U10 · FY2002 · CA
Pharmacogenetic Determinants of Vincristine Toxicity and Response
$485,538Jamie L Renbarger · Indiana University Indianapolis · R01 · FY2014 · HD
Phase IIb trial of CD24Fc for GVHD prophylaxis, IND 127,363 (01/29/2016)
$485,432Yang Liu · Oncoimmune, Inc. · R01 · FY2020 · FD
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
$485,376Giovanna Tosato · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Normal ABL1 kinase as tumor suppressor and therapeutic target in leukemia
$485,369Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2017 · CA
Normal ABL1 kinase as tumor suppressor and therapeutic target in leukemia
$485,369Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2018 · CA
Project 4: Secondary Cancers Among NF1 Cancer Survivors
$485,346Jean Nakamura · Indiana University Indianapolis · U54 · FY2019 · CA
Dissecting and Predicting Lethal Prostate Cancer using Biologically Informed Artificial Intelligence
$485,271Eliezer M Van Allen · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs
$485,193Joseph C Wu · Stanford University · R01 · FY2015 · HL
Signal Transduction by Non-transmembrane PTPs
$485,178Beth Israel Deaconess Medical Center · R37 · FY2004 · CA
AUTOMATED CLOSED SYSTEM FOR DMSO REMOVAL FROM PERIPHERAL BLOOD STEM CELLS
$485,178Erik J Woods · General Biotechnology, Llc · R44 · FY2008 · HL
Optimizing HER2-targeting using RNA- and DNA-based predictive algorithms
$485,168Lisa A Carey · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Dual Kinase and LSD1 Inhibition in Acute Myeloid Leukemia
$485,097Theodore Paul Braun · Oregon Health & Science University · R01 · FY2023 · CA
Clinical Consortia (Pediatric & Adult)
$485,069Stephen E Sallan · Dana-Farber Cancer Inst · P01 · FY2007 · CA
Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target?
$485,048Guido Marcucci · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Reconstitution of Regulatory T Cells After Stem Cell Transplantation
$485,000Jerome Ritz · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Diet change among prostate cancer patients under expectant management
$485,000James Marshall · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA
Targeting NSD1 in leukemia
$484,924Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
SAN JUAN MB COMMUNITY CLINICAL ONCOLOGY PROGRAM
$484,826Luis Baez · San Juan City Hospital · U10 · FY2007 · CA
Metabolic control of normal and malignant hematopoiesis
$484,803Andrew Michael Intlekofer · Sloan-Kettering Inst Can Research · R37 · FY2020 · CA
Metabolic control of normal and malignant hematopoiesis
$484,803Andrew Michael Intlekofer · Sloan-Kettering Inst Can Research · R37 · FY2022 · CA
Metabolic control of normal and malignant hematopoiesis
$484,803Andrew Michael Intlekofer · Sloan-Kettering Inst Can Research · R37 · FY2021 · CA
Comparative Feline Genomics: High-Throughput BACPACFosmid Mapping of the MHC
$484,798Stephen J O'Brien · Basic Sciences · Z01 · FY2007 · CA
Comparative Genomics: Mechanism(s) Against Emerging Infectious Diseases
$484,798Stephen J O'Brien · Basic Sciences · Z01 · FY2007 · CA
Structural understanding of 7SK-snRNP mediated transcriptional regulation
$484,772Victoria Manuel D'souza · Harvard University · R01 · FY2024 · GM